Ampio Pharmaceuticals, Inc. (AMPE) Q4 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day everyone and welcome to NPO's fourth quarter 2021 earnings conference call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Dan Stokely, Chief Financial Officer. Please go ahead, sir. Hello everyone and welcome to NPO's fourth quarter 2021 financial results and business update call. My name is Dan Stokely. And I'm joined today by Chairman and CEO Mike Martino and President and Chief Operating Officer Holly Cherevka. Our fourth quarter 2021 10-K and earnings information was released today, March 29, 2022, at 4.10 p.m. Eastern Time and can be found in the investor section on our website, ampiopharma.com, under financial filings. Before we begin, I'd like to remind our listeners that this presentation may contain forward-looking statements about our business. You should not place undue reliance on forward-looking statements, as these statements are based upon our current expectations, forecasts, and assumptions, and are subject to significant risks and uncertainties. These statements may be identified by words such as may, will, should, could, expect, intend, plan, anticipate, believe, estimate, predict, potential, forecast, continue, or the negative of these terms or other words or terms of similar meaning. Risks and uncertainties that could cause our actual results to differ materially from those set forth in any forward-looking statements include that are not limited to the matters listed under risk factors in our annual report on Form 10-K for the year ended December 31st, 2021, which is also on file with the Securities and Exchange Commission, as well as other risks detailed in our subsequent filings with the Securities and Exchange Commission. These reports are also available at www.sec.gov. Statements and informati...